Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)

Conclusion, At 12 months, SRS and/or neurosurgery provided good control with low toxicity. WBRT was not required in 95 % of cases. This small study supports the practice change from WBRT to local therapies for MHBC BrM.PMID:38340685 | DOI:10.1016/j.breast.2024.103675

Source: Breast - February 10, 2024 Category: Cancer & Oncology Authors: Claire Phillips Mark B Pinkham Alisha Moore Joseph Sia Rosalind L Jeffree Mustafa Khasraw Anthony Kam Mathias Bressel Annette Haworth Source Type: research